CureVac N.V. (NASDAQ:CVAC) Q3 2024 Earnings Convention Name November 12, 2024 9:00 AM ET
Firm Individuals
Sarah Fakih – Vice President of Company Communications and Investor Relations
Alexander Zehnder – Chief Government Officer
Axel Malkomes – Chief Monetary Officer
Myriam Mendila – Chief Improvement Officer
Rudiger Wolff – Senior Vice President of Finance
Convention Name Individuals
Charlie Yang – Financial institution of America Merrill Lynch
CJ Yeh – Leerink Companions
Roy Buchanan – Residents JMP
Operator
Greetings and welcome to the CureVac Monetary Outcomes and Enterprise Replace for the Third Quarter and First 9 Months of 2024 Convention Name. Right now, all individuals are in a listen-only mode. A matter-and-answer session will observe the formal presentation. [Operator Instructions] As a reminder, this convention is being recorded.
It’s now my pleasure to introduce your host, Sarah Fakih, Vice President of Company Communications and Investor Relations. Thanks. Chances are you’ll start.
Sarah Fakih
Thanks. Good morning, good afternoon, and welcome to our convention name. My title is Sarah Fakih, I am the Vice President of Company Communications and Investor Relations at CureVac.
Please let me introduce at the moment’s audio system. On the decision with me from CureVac are Alexander Zehnder, Chief Government Officer of CureVac; Myriam Mendila, our Chief Scientific Officer; and our Chief Monetary Officer, Axel Malkomes. Rudiger Wolff, Senior Vice President of Finance will likely be out there for the Q&A session. Please word that this name is being webcast dwell and will likely be archived on the Occasions & Displays part underneath Investor Relations on our web site.
Earlier than we start, a couple of forward-looking statements. The discussions and responses to your questions on this name replicate administration’s view as of at the moment, Tuesday, November 12, 2024. We will likely be making statements and offering responses to your questions that state our intentions, beliefs, expectations, or predictions of the long run. These represent forward-looking statements for the aim
